Condition:   Spondylitis, Ankylosing
Interventions:   Drug: Ixekizumab;   Drug: Placebo;   Drug: Adalimumab
Sponsors:   Eli Lilly and Company;   Eli Lilly and Company
Not yet recruiting - verified September 2013